Orion, your calculations are spot on in terms of number of shares and return to Cellceutix. What I can't agree with is your logic behind the selling of these 100 share blocks in order to keep the share price down. Look at it this way, if they sold all of their shares for an average of 1.80, what would they garner, 15%. This type of return pales to the 30-40% range that they would really target and that can only be reached if the average sale price is above 4 dollars. Lastly, your logic assumes that ASPIRE is the only source of further financing. It would seem that this is not true based on the response from the CEO to Wild4nano's last email. I believe that ASPIRE is in it for more and that CTIX will definitely deliver more.
GO CTIX